Near-Infrared Imaging System Used As Pancreatic Cancer Diagnostic

Recently scientists from different Boston area institutions have shown that a new type of medical imaging, called optical coherence tomography (OCT), can be used as a  non-invasive means to diagnose the difference between low and high risk cysts within the pancreas. This new technique will allow doctors to treat potentially life threatening situations easily and with a high degree of accuracy.

A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc. has demonstrated for the first time that optical coherence tomography (OCT), a high resolution optical imaging technique that works by bouncing near-infrared laser light off biological tissue, can reliably distinguish between pancreatic cysts that are low-risk and high-risk for becoming malignant. Other optical techniques often fail to provide images that are clear enough for doctors to differentiate between the two types.

To test the diagnostic potential of OCT imaging, researchers used the technique to examine surgically removed pancreatic tissue samples from patients with cystic lesions. By identifying unique features of the high-risk cysts that appeared in the OCT scans, the team developed a set of visual criteria to differentiate between high and low risk cysts. They then tested the criteria by comparing OCT diagnoses to those obtained by examining thin slices of the pancreatic tissue under a microscope. Their results, described in the August issue of the Optical Society’s (OSA) open-access journalBiomedical Optics Express, showed that OCT allowed clinicians to reliably differentiate between low-risk and high-risk cysts with a success rate close to that achieved by microscope-assisted examinations of slices of the same samples.

Future studies by the research team will focus on improving imaging resolution to further differentiate between solid lesions and autoimmune pancreatitis, and test this technology in vivo. They recently received FDA approval for testing this technology in human patients by using an OCT probe small enough to be inserted into the pancreas through a biopsy needle, which will be guided into suspect masses in the pancreas by endoscopic ultrasound imaging. A pilot clinical study is planned to start within the next couple of months. If in vivo data will prove reliable differentiation between the two types of cysts, a study in a larger number of patients will be planned, contingent on NIH funding and FDA approval.

Read more here

Share

Posted: August 23rd, 2011 under Uncategorized.

RSS Medical Imaging News

  • Novel ultrasound technology to screen for heart conditions developed by engineers October 29, 2014
    Engineers have determined, for the first time, the impact of a ring-shaped vortex on transporting blood flow in normal and abnormal ventricles within the human heart, and have developed a novel ultrasound technology that makes screening cheaper and much easier, making it possible to reach a large number of people and even infants.
  • Brain abnormalities found in chronic fatigue patients October 29, 2014
    An imaging study has found distinct differences between the brains of patients with chronic fatigue syndrome and those of healthy people.
  • New technology shows promise for delivery of therapeutics to the brain October 28, 2014
    Researchers have created “a tool for blood-barrier-brain disruption that uses bursts of sub-microsecond bipolar pulses to enhance the transfer of large molecules to the brain.” According to the authors, the current medical use of chemotherapy to treat brain cancer can be inefficient because of the blood-brain-barrier that impedes the delivery of drugs out of […]
  • Tomosynthesis improves cancer detection in women with dense breast tissue October 28, 2014
    As of October 2014, 19 states have enacted laws requiring women to be directly informed if they have dense breasts and would benefit from supplemental screening. However, the recommended type of supplemental screening for women with dense breasts remains unclear. With 15 additional states considering similar laws and federal legislation introduced, physician […]
  • Preventative action prior to brain surgery: Ultra-high-field MRI reveals language centers in brain in much more detail October 28, 2014
    It is now possible, for the first time, to demonstrate that the areas of the brain that are important for understanding language can be pinpointed much more accurately using ultra-high-field MRI (7 Tesla) than with conventional clinical MRI scanners. This research helps to protect these areas more effectively during brain surgery and avoid accidentally damag […]
  • Ultrasound guides tongue to pronounce 'R' sounds October 27, 2014
    Using ultrasound technology to visualize the tongue’s shape and movement can help children with difficulty pronouncing “r” sounds, according to a small study. The ultrasound intervention was effective when individuals were allowed to make different shapes with their tongue in order to produce the "r" sound, rather than being instructed to make a sp […]
  • Brain development in utero observed by researchers October 27, 2014
    New investigation methods using functional magnetic resonance tomography (fMRT) offer insights into fetal brain development. These "in vivo" observations will uncover different stages of the brain's development. A research group has observed that parts of the brain that are later responsible for sight are already active at this stage.
  • New hope for potential prostate cancer patients October 25, 2014
    It has been more than 30 years since the last major advancement in prostate cancer screening technology, and the latest advancement is now available in the United States. It is estimated that 2014 will see more than 240,000 new cases of prostate cancer, and more than 29,000 deaths from the disease.
  • Breast cancer tumor response to neoadjuvant chemotherapy measured October 23, 2014
    It may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast cancer tumors before surgery, a study shows.
  • New window of opportunity to prevent cardiovascular, diseases October 23, 2014
    Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early brain imaging tests long before heart attacks or strokes occur, according to a systematic review conducted by a team of cardiologists, neuroscientists, and psychiatrists.

News Items

Links